Table 3.
Cross-sectional Studies Linking Contraceptive Use with Prevalent BV
| Author, Year | Group | Odds Ratio or RR (95% Confidence interval) |
|---|---|---|
| Riggs, 2007[ 13 ] | Oral contraceptives | 0.76 (0.63 – 0.90) |
| DMPA/Implant | 0.64 (0.53 – 0.76) | |
| Tubal ligation | 1.38 (1.11 – 1.71) | |
| Condom | 1.0 (0.86 – 1.16) | |
|
Shoubnikova,
1997[ 81 ] |
Combined oral contraceptives | 0.4 (0.2 – 0.8) |
| IUD | 0.7 (0.3 – 1.6) | |
| Condom | 0.3 (0.1 – 0.9) | |
| Calzolari, 2000[ 82 ] | Combined oral contraceptives | 0.43 (0.22 – 0.76) |
| IUD | 2.98 (1.66 – 5.34) | |
| Condom | 0.56 (0.33 – 0.96) | |
| Holzman, 2001[ 83 ] | Hormonal Contraceptives | 0.5 (0.2 – 0.8) |
|
Hutchinson,
2007[ 84 ] |
Condoms | 0.55 (0.34 – 0.88) |